Functional sheet for adjuvant treatment on diabetes type II and production method thereof

A technology for adjuvant treatment and diabetes, applied in metabolic diseases, pharmaceutical formulations, medical preparations containing active ingredients, etc., to achieve the effect of reducing peripheral insulin resistance, wide sources, and scientific formulations

Inactive Publication Date: 2016-06-22
HARBIN MO MEDICAL BIOLOGICAL TECH CO LTD
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The ability to produce insulin in the body of patients with type 2 diabetes is not completely lost. Some patients even produce too much insulin in the body, but the effect of insulin is poor. Therefore, the insulin in the body of the patient is relatively deficient. insulin secretion
[0003] Currently, the products on the market for assisting hypoglycemia are mainly composed of oral hypoglycemic western medicine and insulin. rebound
Most patients take long-term hypoglycemic western medicines to cause damage to the heart, brain, kidneys and other organs, and a class of drugs that stimulate islets are effective in the short term, but they tend to accelerate the aging of islet functions, damage islet tissue, and cause multiple complications

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Functional sheet for adjuvant treatment on diabetes type II and production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach 1

[0028] A functional tablet for adjuvant treatment of type II diabetes, characterized in that it is made of the following raw materials in percentage by weight, 2-5% of ginkgo leaf extract, 1-2% of mulberry leaf extract, 2% of sea-buckthorn extract ~5%, grape seed extract 1~3%, black fungus polysaccharide 2~5%, Armillaria polysaccharide 2~5%, Ganoderma lucidum polysaccharide 1~5%, Agaricus blazei polysaccharide 1~5%, Grifola frondosa polysaccharide 1 ~5%, starch 30~50%, microcrystalline cellulose 10~20%, dextrin 5~10%, magnesium stearate 0.5%.

[0029] The weight percentages of various raw materials are: Ginkgo biloba extract 4%, mulberry leaf extract 1.5%, seabuckthorn extract 4%, grape seed extract 2%, black fungus polysaccharide 4%, Armillaria polysaccharide 4%, Ganoderma lucidum Polysaccharide 4%, Agaricus blazei polysaccharide 4%, Grifola frondosa polysaccharide 4%, Starch 45%, Microcrystalline cellulose 15%, Dextrin 8%, Magnesium stearate 0.5%.

[0030] The main pr...

Embodiment approach 2

[0039] The preparation process steps of this tablet are as follows:

[0040] 1. Ginkgo biloba leaves, mulberry leaves, seabuckthorns, grape seeds, black fungus, Armillaria, Ganoderma lucidum, Agaricus blazei, and Grifola frondosa are purified and passed the inspection for later use;

[0041] 2. Take ginkgo leaves, mulberry leaves, seabuckthorn, and grape seeds and use 70% ethanol to reflux extract twice, add 8 times the amount of solvent each time, and reflux each time for 2 hours. After the extract is filtered, the residue is stored separately, and the filtrate is combined , recovering ethanol in the filtrate and concentrating it to a clear paste with a relative density of 1.30~1.35, measuring at 60°C, drying under reduced pressure at 65°C, crushing, passing through a 80-mesh sieve, and set aside;

[0042] 3. Preparation of edible fungus extract: Take black fungus, Armillaria armillaria, Ganoderma lucidum, Agaricus blazei, and Grifola frondosa into extraction tanks, a...

Embodiment approach 3

[0049] The preparation process steps of this tablet are as follows:

[0050] 1. Ginkgo biloba leaves, mulberry leaves, seabuckthorns, grape seeds, black fungus, Armillaria, Ganoderma lucidum, Agaricus blazei, and Grifola frondosa are purified and passed the inspection for later use;

[0051] 2. Take ginkgo leaves, mulberry leaves, seabuckthorn, and grape seeds and use 70% ethanol to reflux extract twice, add 8 times the amount of solvent each time, and reflux each time for 2 hours. After the extract is filtered, the residue is stored separately, and the filtrate is combined , recovering ethanol in the filtrate and concentrating it to a clear paste with a relative density of 1.30~1.35, measuring at 60°C, drying under reduced pressure at 65°C, crushing, passing through a 80-mesh sieve, and set aside;

[0052] 3. Preparation of edible fungus extract: Take black fungus, Armillaria armillaria, Ganoderma lucidum, Agaricus blazei, and Grifola frondosa into extraction tanks, a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a functional sheet for adjuvant treatment on diabetes type II and a production method thereof. The functional sheet is prepared from ginkgo leaf extract, mulberry leaf extract, sea buckthorn extract, grape seed extract, black fungus polysaccharide, armillaria mellea polysaccharide, ganoderan, agaricus blazei murill polysaccharide, grifolan, starch, microcrystalline cellulose, dextrin and magnesium stearate. The production method comprises material selection, extract powder preparation, domestic fungus extract product preparation, weighing and mixing, granulation, tabletting and packaging. The functional sheet is rich in anthocyanidin, flavonoids and polysaccharide of edible fungi. The ingredients are combined, mainly act on lung, spleen and kidney channels, have effects of tonifying Qi and Yin, invigorating spleen and kidney, and engendering liquid and moistening dryness and can realize purposes of assistantly reducing blood glucose and improving patient living quality.

Description

Technical field: [0001] The invention relates to the technical field of health products, in particular to a functional tablet for auxiliary treatment of type II diabetes and a production method thereof. Background technique [0002] Diabetes is a clinical common disease, frequently-occurring disease, and its incidence rate has been rapidly spreading nationwide in recent years. There are more than 40 million diabetic patients in my country, and 3.2 million people worldwide die each year due to diabetes. Type II diabetes, formerly known as adult-onset diabetes, usually occurs after the age of 35 to 40, accounting for more than 90% of diabetic patients. The ability to produce insulin in the body of patients with type 2 diabetes is not completely lost, and some patients even produce too much insulin in the body, but the effect of insulin is poor, so the insulin in the body of the patient is relatively deficient, which can be stimulated by some oral drugs Insulin secretion. How...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A23L1/09A23L1/28A61K36/87A61K9/20A61P3/10A61K31/715
Inventor 戴路
Owner HARBIN MO MEDICAL BIOLOGICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap